Literature DB >> 10807369

From the Food and Drug Administration.

.   

Abstract

Mesh:

Substances:

Year:  2000        PMID: 10807369

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  26 in total

1.  Cochrane's epitaph for cisapride in childhood gastro-oesophageal reflux.

Authors:  B Bourke; B Drumm
Journal:  Arch Dis Child       Date:  2002-02       Impact factor: 3.791

2.  The Food and Drug Administration and the Future of Drug Development for the Treatment of Diabetes.

Authors:  Eric P Brass
Journal:  Diabetes Spectr       Date:  2014-05

3.  Identifying dominant inpatient trends leveraging electronic physician orders:The Medical Gopher 1993-2016.

Authors:  Paul Dexter; Jeff Warvel; Blaine Takesue
Journal:  AMIA Annu Symp Proc       Date:  2018-12-05

Review 4.  Facilitating return of bowel function after colorectal surgery: alvimopan and gum chewing.

Authors:  Deborah Keller; Sharon L Stein
Journal:  Clin Colon Rectal Surg       Date:  2013-09

Review 5.  Appropriate Use of Laxatives in the Older Person.

Authors:  Lisa G Pont; Murray Fisher; Kylie Williams
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

Review 6.  Cisapride treatment for gastro-oesophageal reflux in children.

Authors:  Suzanna Maclennan; Cristina Augood; Lucinda Cash-Gibson; Stuart Logan; Ruth E Gilbert
Journal:  Cochrane Database Syst Rev       Date:  2010-04-14

Review 7.  Lansoprazole: an update of its place in the management of acid-related disorders.

Authors:  A J Matheson; B Jarvis
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 8.  The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.

Authors:  Hanford Yau; Kathya Rivera; Romina Lomonaco; Kenneth Cusi
Journal:  Curr Diab Rep       Date:  2013-06       Impact factor: 4.810

9.  Laboratory monitoring of drugs at initiation of therapy in ambulatory care.

Authors:  Marsha A Raebel; Ella E Lyons; Susan E Andrade; K Arnold Chan; Elizabeth A Chester; Robert L Davis; Jennifer L Ellis; Adrianne Feldstein; Margaret J Gunter; Jennifer Elston Lafata; Charron L Long; David J Magid; Joseph V Selby; Steven R Simon; Richard Platt
Journal:  J Gen Intern Med       Date:  2005-12       Impact factor: 5.128

10.  Diminishing efficacy of combination therapy, response-heterogeneity, and treatment intolerance limit the attainability of tight risk factor control in patients with diabetes.

Authors:  Justin W Timbie; Rodney A Hayward; Sandeep Vijan
Journal:  Health Serv Res       Date:  2010-01-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.